To determine whether miR-424(322) and PD-L1 are involved in ovarian cancer chemoresistance, we investigated the association between the miR-424(322) and PD-L1 levels in primary ovarian tumours and their response to platinum-based chemotherapy. This evidence concerns the gene CD274 and ovarian neoplasm.